Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL

SALT LAKE CITY, Feb. 15, 2023. Sera Prognostics Inc., The Pregnancy Company, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced top-line results from the...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials